Voucher and NEW Patient Copay Assistance information is now available here

~90% of patients pay $10 or less with financial assistance offerings1

For all new,
non-sampled patients

30-day Free Trial Voucher

New, non-sampled patients can receive
their first
30 days of AUSTEDO XR for free.

Voucher available at

Remind pharmacy to apply.

Terms & Conditions apply

For eligible patients with
commercial insurance

Copay Card

Patients may pay as little as $0 per
month for AUSTEDO XR.

Patients must self-enroll at

Visit AUSTEDOcardform.com to send a
to patients with more information.

Terms & Conditions apply

For patients with
Medicare Part D

Low-income Subsidy

Patients who qualify for and utilize LIS
may pay as little as $11.20 per month.1

Shared Solutions can help patients understand if they qualify. To enroll in Shared Solutions, patients can visit MySharedSolutions.com.

For uninsured or
underinsured patients

Patient Assistance Program

To qualify, patient must:

  • Apply for assistance
  • Be a legal US resident
  • Meet the insurance
    eligibility criteria
  • Be below the income
    eligibility limit

To apply, patient must complete the application on MySharedSolutions.com.

~88% of AUSTEDO prescriptions are successfully processed and approved1

  • Access for 94% of patients with insurance coverage (commercial, Medicare Part D, and Medicaid)1
  • Available at both specialty and retail pharmacies

Request a visit from an Access & Reimbursement Manager to help with prior authorizations, affordability programs, payer coverage, and reimbursement support*

*If you do not have an Access & Reimbursement Manager, reach out to your sales representative.

Blue Prescription Coverage Tool Icon

coverage tool

Find health plans that cover AUSTEDO® XR (deutetrabenazine) extended-release tablets in your state

Find health plans that cover AUSTEDO® XR (deutetrabenazine) extended-release tablets in your state

Enter in a ZIP code or select a state, then select a plan type, select a plan, and click “Search.”



Dropdown Arrow
  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • District of Columbia
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Puerto Rico
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
Dropdown Arrow

Plan Type

Dropdown Arrow
  • Commercial
  • EGWP
  • Employer
  • Fed Prog
  • HIX
  • MAC A
  • MAC B
  • Managed Medicaid
  • Medicare MA
  • Medicare PDP
  • Medicare SN
  • Medi-Medi
  • Municipal Plan
  • PACE
  • PBM
  • Pvt HIX
  • State Medicaid
  • Union
Dropdown Arrow

Select Plan

Dropdown Arrow
Dropdown Arrow

    NA, not available.
    Please note that plans may have multiple formularies and they are subject to change by the plan. Please check with the health plan directly to confirm formulary status, requirements, and coverage information for individual patients.
    Source: Fingertip Formulary database as of 04/2024.
    This information is intended only to show the formulary coverage status for each product and should not be construed to make any comparisons of safety, efficacy, or other clinical outcome.

    Patients typically pay less out of pocket vs tetrabenazine1†

    Commercial Insurance Case Study

    Dual-eligible with LIS Case Study

    Patient Tina Image

    Meet Tina

    • Age: 50
    • Diagnosed with Huntington’s disease 6 years ago
    • Recently prescribed AUSTEDO for her chorea symptoms
    • AUSTEDO is covered in a preferred position on Tina’s commercial healthcare plan
    • Tina pays $0 OOP for AUSTEDO

     $25 OOP cost

    – $25 application of Copay Card

     $0 net OOP cost

    ~80% of commercial patients on AUSTEDO will pay $0 out of pocket vs 39% of patients on tetrabenazine1§

    Time period: 1/2022 through 2/2023.1

    See Copay Card terms and conditions on AUSTEDOcopayterms.com.

    §Time period: rolling quarter 1/2023.1

    Patient Frank Image

    Meet Frank

    • Age: 47
    • Diagnosed with Huntington’s disease 6 years ago
    • Recently prescribed AUSTEDO for his chorea symptoms
    • Frank is dual-eligible and qualifies for LIS
    • He qualifies for Medicare earlier than age 65 due to disability because of his progressive HD condition
    • He qualifies for full Medicare due to low income and limited resources
    • Given these circumstances, Frank automatically qualifies for Medicare LIS
    • Frank pays $11.20 per month OOP for AUSTEDO2

    90% of all Medicare Part D patients pay $10 or less out of pocket for AUSTEDO1‡

    Time period: 1/2022 through 2/2023.1

    Time period: 11/2022 through 1/2023.1

    LIS, low-income subsidy; OOP, out of pocket.

    REFERENCES: 1. Data on file. Parsippany, NJ: Teva Neuroscience, Inc. 2. Medicare. Find your level of Extra Help (Part D). Accessed January 9, 2023. https://www.medicare.gov/your-medicare-costs/get-help-paying-costs/find-your-level-of-extra-help-part-d